<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39334742</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3921</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Antioxidants (Basel, Switzerland)</Title><ISOAbbreviation>Antioxidants (Basel)</ISOAbbreviation></Journal><ArticleTitle>Multiple Mechanisms of Action of Sulfodyne<sup>®</sup>, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1083</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antiox13091083</ELocationID><Abstract><AbstractText>Few therapeutic options are available to treat COVID-19. The KEAP1/NRF2 pathway, the major redox-responsive pathway, has emerged as a potential therapeutic target for COVID-19 as it regulates redox homeostasis and inflammation that are altered during SARS-CoV-2 infection. Here, we characterized the effects of NRF2-agonist Sulfodyne<sup>®</sup>, a stabilized natural Sulforaphane, in cellular and animal models of SARS-CoV-2 infection. In pulmonary or colonic epithelial cell lines, Sulfodyne<sup>®</sup> elicited a more efficient inhibition of SARS-CoV-2 replication than NRF2-agonists DMF and CDDO. This antiviral activity was not dependent on NRF2 but was associated with the regulation of several metabolic pathways, including the inhibition of ER stress and mTOR signaling, which are activated during SARS-CoV-2 infection. Sulfodyne<sup>®</sup> also decreased SARS-CoV-2 mediated inflammatory responses by inhibiting the delayed induction of IFNB1 and type I IFN-stimulated genes in infected epithelial cell lines and by reducing the activation of human by-stander monocytes recruited after SARS-CoV-2 infection. In K18-hACE2 mice infected with SARS-CoV-2, Sulfodyne<sup>®</sup> treatment reduced both early lung viral load and disease severity by fine-tuning IFN-beta levels. Altogether, these results provide evidence for multiple mechanisms that underlie the antiviral and anti-inflammatory activities of Sulfodyne<sup>®</sup> and pinpoint Sulfodyne<sup>®</sup> as a potent therapeutic agent against pathogenic effects of SARS-CoV-2 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romeo</LastName><ForeName>Paul-Henri</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conquet</LastName><ForeName>Laurine</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1911-4887</Identifier><AffiliationInfo><Affiliation>Mouse Genetics Laboratory, Université Paris Cité, Institut Pasteur, 75724 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messiaen</LastName><ForeName>Sébastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory on Development of the Gonads (LDG/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Development of the Gonads (LDG/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascal</LastName><ForeName>Quentin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Stéphanie G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bravard</LastName><ForeName>Anne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0314-9092</Identifier><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernardino-Sgherri</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dereuddre-Bosquet</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-6682-6313</Identifier><AffiliationInfo><Affiliation>Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montagutelli</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-9372-5398</Identifier><AffiliationInfo><Affiliation>Mouse Genetics Laboratory, Université Paris Cité, Institut Pasteur, 75724 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Grand</LastName><ForeName>Roger</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4928-4484</Identifier><AffiliationInfo><Affiliation>Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petit</LastName><ForeName>Vanessa</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferri</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris-Saclay, Inserm, CEA, 92265 Fontenay-aux-Roses, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2020</GrantID><Agency>Air Liquide (France)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antioxidants (Basel)</MedlineTA><NlmUniqueID>101668981</NlmUniqueID><ISSNLinking>2076-3921</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Nrf2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">interferon-beta</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39334742</ArticleId><ArticleId IdType="pmc">PMC11429452</ArticleId><ArticleId IdType="doi">10.3390/antiox13091083</ArticleId><ArticleId IdType="pii">antiox13091083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussi S.S., Hammond J.L., Gerstenberger B.S., Anderson A.S. Therapeutics for COVID-19. Nat. Microbiol. 2023;8:771–786. doi: 10.1038/s41564-023-01356-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01356-4</ArticleId><ArticleId IdType="pubmed">37142688</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonelli C., Chio I.I.C., Tuveson D.A. Transcriptional Regulation by Nrf2. Antioxid. Redox Signal. 2018;29:1727–1745. doi: 10.1089/ars.2017.7342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7342</ArticleId><ArticleId IdType="pmc">PMC6208165</ArticleId><ArticleId IdType="pubmed">28899199</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M., Kensler T.W., Motohashi H. The KEAP1-NRF2 System: A Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis. Physiol. Rev. 2018;98:1169–1203. doi: 10.1152/physrev.00023.2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00023.2017</ArticleId><ArticleId IdType="pmc">PMC9762786</ArticleId><ArticleId IdType="pubmed">29717933</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi E.H., Suzuki T., Funayama R., Nagashima T., Hayashi M., Sekine H., Tanaka N., Moriguchi T., Motohashi H., Nakayama K., et al. Nrf2 Suppresses Macrophage Inflammatory Response by Blocking Proinflammatory Cytokine Transcription. Nat. Commun. 2016;7:11624. doi: 10.1038/ncomms11624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11624</ArticleId><ArticleId IdType="pmc">PMC4879264</ArticleId><ArticleId IdType="pubmed">27211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hybertson B.M., Gao B., Bose S.K., McCord J.M. Oxidative Stress in Health and Disease: The Therapeutic Potential of Nrf2 Activation. Mol. Aspects Med. 2011;32:234–246. doi: 10.1016/j.mam.2011.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2011.10.006</ArticleId><ArticleId IdType="pubmed">22020111</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramezani A., Nahad M.P., Faghihloo E. The Role of Nrf2 Transcription Factor in Viral Infection. J. Cell Biochem. 2018;119:6366–6382. doi: 10.1002/jcb.26897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.26897</ArticleId><ArticleId IdType="pubmed">29737559</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam M.S., Czajkowsky D.M. SARS-CoV-2 Infection and Oxidative Stress: Pathophysiological Insight into Thrombosis and Therapeutic Opportunities. Cytokine Growth Factor. Rev. 2022;63:44–57. doi: 10.1016/j.cytogfr.2021.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8591899</ArticleId><ArticleId IdType="pubmed">34836751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gain C., Song S., Angtuaco T., Satta S., Kelesidis T. The Role of Oxidative Stress in the Pathogenesis of Infections with Coronaviruses. Front. Microbiol. 2022;13:1111930. doi: 10.3389/fmicb.2022.1111930.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.1111930</ArticleId><ArticleId IdType="pmc">PMC9880066</ArticleId><ArticleId IdType="pubmed">36713204</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronel P.M.V., Pereira I.C., Basilio D.C.L.S., Espinoça I.T., de Souza K.F.S., Ota R.S.N., de Almeida E.B., Paredes-Gamero E.J., Wilhelm Filho D., Perdomo R.T., et al. Biomarkers of Oxidative Stress and Inflammation in Subjects with COVID-19: Characterization and Prognosis of the Disease. Microb. Pathog. 2023;184:106339. doi: 10.1016/j.micpath.2023.106339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2023.106339</ArticleId><ArticleId IdType="pubmed">37690769</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Farahani E., Thyrsted J., Blay-Cadanet J., Herengt A., Idorn M., Hait A., Hernaez B., Knudsen A., Iversen M.B., et al. SARS-CoV2-Mediated Suppression of NRF2-Signaling Reveals Potent Antiviral and Anti-Inflammatory Activity of 4-Octyl-Itaconate and Dimethyl Fumarate. Nat. Commun. 2020;11:4938. doi: 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18764-3</ArticleId><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gümüş H., Erat T., Öztürk İ., Demir A., Koyuncu I. Oxidative Stress and Decreased Nrf2 Level in Pediatric Patients with COVID-19. J. Med. Virol. 2022;94:2259–2264. doi: 10.1002/jmv.27640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27640</ArticleId><ArticleId IdType="pmc">PMC9088523</ArticleId><ArticleId IdType="pubmed">35128704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Wang J., Wang L., Aliyari S., Cheng G. SARS-CoV-2 Virus NSP14 Impairs NRF2/HMOX1 Activation by Targeting Sirtuin 1. Cell Mol. Immunol. 2022;19:872–882. doi: 10.1038/s41423-022-00887-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-022-00887-w</ArticleId><ArticleId IdType="pmc">PMC9217730</ArticleId><ArticleId IdType="pubmed">35732914</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L., Du J., Yang S., Zheng B., Shen J., Huang J., Cao L., Huang S., Liu X., Guo L., et al. SARS-CoV-2 ORF3a Sensitizes Cells to Ferroptosis via Keap1-NRF2 Axis. Redox Biol. 2023;63:102752. doi: 10.1016/j.redox.2023.102752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2023.102752</ArticleId><ArticleId IdType="pmc">PMC10202901</ArticleId><ArticleId IdType="pubmed">37245288</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y., Haas de Mello A., Morris D.R., Jones-Hall Y.L., Ivanciuc T., Sattler R.A., Paessler S., Menachery V.D., Garofalo R.P., Casola A. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection. Microbiol. Spectr. 2023;11:e0037823. doi: 10.1128/spectrum.00378-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00378-23</ArticleId><ArticleId IdType="pmc">PMC10269779</ArticleId><ArticleId IdType="pubmed">37022178</ArticleId></ArticleIdList></Reference><Reference><Citation>McCord J.M., Hybertson B.M., Cota-Gomez A., Geraci K.P., Gao B. Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19. Antioxidants. 2020;9:518. doi: 10.3390/antiox9060518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9060518</ArticleId><ArticleId IdType="pmc">PMC7346195</ArticleId><ArticleId IdType="pubmed">32545518</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H.A., Zhong Y., Sanborn M.A., Teoh T.C., Ruan J., Yusof R., Hang J., Henderson M.J., Fang S. Small Molecule Grp94 Inhibitors Block Dengue and Zika Virus Replication. Antiviral Res. 2019;171:104590. doi: 10.1016/j.antiviral.2019.104590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2019.104590</ArticleId><ArticleId IdType="pmc">PMC6801034</ArticleId><ArticleId IdType="pubmed">31421166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez A.A., Bullen C.K., Villabona-Rueda A.F., Thompson E.A., Turner M.L., Merino V.F., Yan Y., Kim J., Davis S.L., Komm O., et al. Sulforaphane Exhibits Antiviral Activity against Pandemic SARS-CoV-2 and Seasonal HCoV-OC43 Coronaviruses in Vitro and in Mice. Commun. Biol. 2022;5:242. doi: 10.1038/s42003-022-03189-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-03189-z</ArticleId><ArticleId IdType="pmc">PMC8933402</ArticleId><ArticleId IdType="pubmed">35304580</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkova-Kostova A.T., Fahey J.W., Kostov R.V., Kensler T.W. KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane. Trends Food Sci. Technol. 2017;69:257–269. doi: 10.1016/j.tifs.2017.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2017.02.002</ArticleId><ArticleId IdType="pmc">PMC5725197</ArticleId><ArticleId IdType="pubmed">29242678</ArticleId></ArticleIdList></Reference><Reference><Citation>Habtemariam S. Anti-Inflammatory Therapeutic Mechanisms of Isothiocyanates: Insights from Sulforaphane. Biomedicines. 2024;12:1169. doi: 10.3390/biomedicines12061169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines12061169</ArticleId><ArticleId IdType="pmc">PMC11200786</ArticleId><ArticleId IdType="pubmed">38927376</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu C., Eggler A.L., Mesecar A.D., van Breemen R.B. Modification of Keap1 Cysteine Residues by Sulforaphane. Chem. Res. Toxicol. 2011;24:515–521. doi: 10.1021/tx100389r.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx100389r</ArticleId><ArticleId IdType="pmc">PMC3086360</ArticleId><ArticleId IdType="pubmed">21391649</ArticleId></ArticleIdList></Reference><Reference><Citation>Treasure K., Harris J., Williamson G. Exploring the Anti-Inflammatory Activity of Sulforaphane. Immunol. Cell Biol. 2023;101:805–828. doi: 10.1111/imcb.12686.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12686</ArticleId><ArticleId IdType="pubmed">37650498</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss E., Herhaus C., Klimo K., Bartsch H., Gerhäuser C. Nuclear Factor Kappa B Is a Molecular Target for Sulforaphane-Mediated Anti-Inflammatory Mechanisms. J. Biol. Chem. 2001;276:32008–32015. doi: 10.1074/jbc.M104794200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M104794200</ArticleId><ArticleId IdType="pubmed">11410599</ArticleId></ArticleIdList></Reference><Reference><Citation>Múnera-Rodríguez A.M., Leiva-Castro C., Sobrino F., López-Enríquez S., Palomares F. Sulforaphane-Mediated Immune Regulation through Inhibition of NF-kB and MAPK Signaling Pathways in Human Dendritic Cells. Biomed. Pharmacother. 2024;177:117056. doi: 10.1016/j.biopha.2024.117056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2024.117056</ArticleId><ArticleId IdType="pubmed">38945082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-N., Kim D.-H., Kim E.-H., Lee M.-H., Kundu J.K., Na H.-K., Cha Y.-N., Surh Y.-J. Sulforaphane Inhibits Phorbol Ester-Stimulated IKK-NF-κB Signaling and COX-2 Expression in Human Mammary Epithelial Cells by Targeting NF-κB Activating Kinase and ERK. Cancer Lett. 2014;351:41–49. doi: 10.1016/j.canlet.2014.03.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2014.03.037</ArticleId><ArticleId IdType="pubmed">24747121</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss E., Gerhäuser C. Time-Dependent Modulation of Thioredoxin Reductase Activity Might Contribute to Sulforaphane-Mediated Inhibition of NF-kappaB Binding to DNA. Antioxid. Redox Signal. 2005;7:1601–1611. doi: 10.1089/ars.2005.7.1601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.1601</ArticleId><ArticleId IdType="pubmed">16356123</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C., Gu C., Lian P., Wazir J., Lu R., Ruan B., Wei L., Li L., Pu W., Peng Z., et al. Sulforaphane Alleviates Psoriasis by Enhancing Antioxidant Defense through KEAP1-NRF2 Pathway Activation and Attenuating Inflammatory Signaling. Cell Death Dis. 2023;14:768. doi: 10.1038/s41419-023-06234-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-023-06234-9</ArticleId><ArticleId IdType="pmc">PMC10676357</ArticleId><ArticleId IdType="pubmed">38007430</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuadrado A., Pajares M., Benito C., Jiménez-Villegas J., Escoll M., Fernández-Ginés R., Garcia Yagüe A.J., Lastra D., Manda G., Rojo A.I., et al. Can Activation of NRF2 Be a Strategy against COVID-19? Trends Pharmacol. Sci. 2020;41:598–610. doi: 10.1016/j.tips.2020.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7359808</ArticleId><ArticleId IdType="pubmed">32711925</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z., Du R., Cooper L., Achi J.G., Dong M., Ran Y., Zhang J., Zhan P., Rong L., Cui Q. Sulforaphane Is a Reversible Covalent Inhibitor of 3-Chymotrypsin-like Protease of SARS-CoV-2. J. Med. Virol. 2023;95:e28609. doi: 10.1002/jmv.28609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28609</ArticleId><ArticleId IdType="pubmed">36840402</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparello J., D’Aversa E., Papi C., Gambari L., Grigolo B., Borgatti M., Finotti A., Gambari R. Sulforaphane Inhibits the Expression of Interleukin-6 and Interleukin-8 Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein. Phytomedicine. 2021;87:153583. doi: 10.1016/j.phymed.2021.153583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153583</ArticleId><ArticleId IdType="pmc">PMC8095027</ArticleId><ArticleId IdType="pubmed">34033999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiser C., Gonul C.P., Olcum M., Genc S. Inhibitory Effects of Sulforaphane on NLRP3 Inflammasome Activation. Mol. Immunol. 2021;140:175–185. doi: 10.1016/j.molimm.2021.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2021.10.014</ArticleId><ArticleId IdType="pubmed">34717147</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey J.W., Wade K.L., Wehage S.L., Holtzclaw W.D., Liu H., Talalay P., Fuchs E., Stephenson K.K. Stabilized Sulforaphane for Clinical Use: Phytochemical Delivery Efficiency. Mol. Nutr. Food Res. 2017;61:1600766. doi: 10.1002/mnfr.201600766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201600766</ArticleId><ArticleId IdType="pubmed">27935214</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., Ghosh A., Lo C.-S., Chenier I., Scholey J.W., Filep J.G., Ingelfinger J.R., Zhang S.-L., Chan J.S.D. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice. Endocrinology. 2018;159:836–852. doi: 10.1210/en.2017-00752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2017-00752</ArticleId><ArticleId IdType="pmc">PMC5774246</ArticleId><ArticleId IdType="pubmed">29211853</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Ma J., Jiang Y. Transcription Factor Nrf2 as a Potential Therapeutic Target for COVID-19. Cell Stress. Chaperones. 2023;28:11–20. doi: 10.1007/s12192-022-01296-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-022-01296-8</ArticleId><ArticleId IdType="pmc">PMC9685020</ArticleId><ArticleId IdType="pubmed">36417098</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelberg S., Gupta S., Svensson Akusjärvi S., Ambikan A.T., Mikaeloff F., Saccon E., Végvári Á., Benfeitas R., Sperk M., Ståhlberg M., et al. Dysregulation in Akt/mTOR/HIF-1 Signaling Identified by Proteo-Transcriptomics of SARS-CoV-2 Infected Cells. Emerg. Microbes Infect. 2020;9:1748–1760. doi: 10.1080/22221751.2020.1799723.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1799723</ArticleId><ArticleId IdType="pmc">PMC7473213</ArticleId><ArticleId IdType="pubmed">32691695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X., Dong X., Ma R., Wang W., Xiao X., Tian Z., Wang C., Wang Y., Li L., Ren L., et al. Activation and Evasion of Type I Interferon Responses by SARS-CoV-2. Nat. Commun. 2020;11:3810. doi: 10.1038/s41467-020-17665-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Ferretti M., Ying B., Descamps H., Lee E., Dittmar M., Lee J.S., Whig K., Kamalia B., Dohnalová L., et al. Pharmacological Activation of STING Blocks SARS-CoV-2 Infection. Sci. Immunol. 2021;6:eabi9007. doi: 10.1126/sciimmunol.abi9007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abi9007</ArticleId><ArticleId IdType="pmc">PMC10021026</ArticleId><ArticleId IdType="pubmed">34010142</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorne L.G., Reuschl A.-K., Zuliani-Alvarez L., Whelan M.V.X., Turner J., Noursadeghi M., Jolly C., Towers G.J. SARS-CoV-2 Sensing by RIG-I and MDA5 Links Epithelial Infection to Macrophage Inflammation. EMBO J. 2021;40:e107826. doi: 10.15252/embj.2021107826.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107826</ArticleId><ArticleId IdType="pmc">PMC8209947</ArticleId><ArticleId IdType="pubmed">34101213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmierski J., Friedmann K., Postmus D., Emanuel J., Fischer C., Jansen J., Richter A., Bosquillon de Jarcy L., Schüler C., Sohn M., et al. Nonproductive Exposure of PBMCs to SARS-CoV-2 Induces Cell-Intrinsic Innate Immune Responses. Mol. Syst. Biol. 2022;18:e10961. doi: 10.15252/msb.202210961.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.202210961</ArticleId><ArticleId IdType="pmc">PMC9382356</ArticleId><ArticleId IdType="pubmed">35975552</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudowska-Sawczuk M., Mroczko B. What Is Currently Known about the Role of CXCL10 in SARS-CoV-2 Infection? Int. J. Mol. Sci. 2022;23:3673. doi: 10.3390/ijms23073673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23073673</ArticleId><ArticleId IdType="pmc">PMC8998241</ArticleId><ArticleId IdType="pubmed">35409036</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebastián-Martín A., Sánchez B.G., Mora-Rodríguez J.M., Bort A., Díaz-Laviada I. Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology. Biomedicines. 2022;10:2026. doi: 10.3390/biomedicines10082026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10082026</ArticleId><ArticleId IdType="pmc">PMC9406088</ArticleId><ArticleId IdType="pubmed">36009573</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulvihill E.E., Drucker D.J. Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors. Endocr. Rev. 2014;35:992–1019. doi: 10.1210/er.2014-1035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2014-1035</ArticleId><ArticleId IdType="pmc">PMC7108477</ArticleId><ArticleId IdType="pubmed">25216328</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazbeck R., Jaenisch S.E., Abbott C.A. Dipeptidyl Peptidase 4 Inhibitors: Applications in Innate Immunity? Biochem. Pharmacol. 2021;188:114517. doi: 10.1016/j.bcp.2021.114517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2021.114517</ArticleId><ArticleId IdType="pmc">PMC7954778</ArticleId><ArticleId IdType="pubmed">33722535</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai M., Iwatsuki-Horimoto K., Hatta M., Loeber S., Halfmann P.J., Nakajima N., Watanabe T., Ujie M., Takahashi K., Ito M., et al. Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development. Proc. Natl. Acad. Sci. USA. 2020;117:16587–16595. doi: 10.1073/pnas.2009799117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2009799117</ArticleId><ArticleId IdType="pmc">PMC7368255</ArticleId><ArticleId IdType="pubmed">32571934</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden J.W., Cline C.R., Zeng X., Garrison A.R., Carey B.D., Mucker E.M., White L.E., Shamblin J.D., Brocato R.L., Liu J., et al. Human Angiotensin-Converting Enzyme 2 Transgenic Mice Infected with SARS-CoV-2 Develop Severe and Fatal Respiratory Disease. JCI Insight. 2020;5:e142032. doi: 10.1172/jci.insight.142032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.142032</ArticleId><ArticleId IdType="pmc">PMC7566707</ArticleId><ArticleId IdType="pubmed">32841215</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolini D., Stabile A.M., Bastianelli S., Giustarini D., Pierucci S., Busti C., Vacca C., Gidari A., Francisci D., Castronari R., et al. SARS-CoV2 Infection Impairs the Metabolism and Redox Function of Cellular Glutathione. Redox Biol. 2021;45:102041. doi: 10.1016/j.redox.2021.102041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.102041</ArticleId><ArticleId IdType="pmc">PMC8190457</ArticleId><ArticleId IdType="pubmed">34146958</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P., Wang X., Sun Y., Zhao H., Cheng F., Wang J., Yang F., Hu J., Zhang H., Wang C.-C., et al. SARS-CoV-2 ORF8 Reshapes the ER through Forming Mixed Disulfides with ER Oxidoreductases. Redox Biol. 2022;54:102388. doi: 10.1016/j.redox.2022.102388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102388</ArticleId><ArticleId IdType="pmc">PMC9239706</ArticleId><ArticleId IdType="pubmed">35792438</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullen P.J., Garcia G., Purkayastha A., Matulionis N., Schmid E.W., Momcilovic M., Sen C., Langerman J., Ramaiah A., Shackelford D.B., et al. SARS-CoV-2 Infection Rewires Host Cell Metabolism and Is Potentially Susceptible to mTORC1 Inhibition. Nat. Commun. 2021;12:1876. doi: 10.1038/s41467-021-22166-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22166-4</ArticleId><ArticleId IdType="pmc">PMC7994801</ArticleId><ArticleId IdType="pubmed">33767183</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni C., Turroni S., Bianchi L., Fabbri D., Motori E., Malaguti M., Leoncini E., Maraldi T., Bini L., Brigidi P., et al. Novel Targets of Sulforaphane in Primary Cardiomyocytes Identified by Proteomic Analysis. PLoS ONE. 2013;8:e83283. doi: 10.1371/journal.pone.0083283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083283</ArticleId><ArticleId IdType="pmc">PMC3859650</ArticleId><ArticleId IdType="pubmed">24349480</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Gilmour A., Ahn Y.-H., de la Vega L., Dinkova-Kostova A.T. The Isothiocyanate Sulforaphane Inhibits mTOR in an NRF2-Independent Manner. Phytomedicine. 2021;86:153062. doi: 10.1016/j.phymed.2019.153062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2019.153062</ArticleId><ArticleId IdType="pmc">PMC8106549</ArticleId><ArticleId IdType="pubmed">31409554</ArticleId></ArticleIdList></Reference><Reference><Citation>Dana A.-H., Alejandro S.-P. Role of Sulforaphane in Endoplasmic Reticulum Homeostasis through Regulation of the Antioxidant Response. Life Sci. 2022;299:120554. doi: 10.1016/j.lfs.2022.120554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.120554</ArticleId><ArticleId IdType="pubmed">35452639</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Rosen L.B., Zhang Q., Michailidis E., Hoffmann H.-H., Zhang Y., Dorgham K., Philippot Q., Rosain J., Béziat V., et al. Autoantibodies against Type I IFNs in Patients with Life-Threatening COVID-19. Science. 2020;370:eabd4585. doi: 10.1126/science.abd4585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., Chen J., Ogishi M., Sabli I.K.D., Hodeib S., Korol C., et al. Inborn Errors of Type I IFN Immunity in Patients with Life-Threatening COVID-19. Science. 2020;370:eabd4570. doi: 10.1126/science.abd4570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4570</ArticleId><ArticleId IdType="pmc">PMC7857407</ArticleId><ArticleId IdType="pubmed">32972995</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P., Gervais A., Le Voyer T., Rosain J., Philippot Q., Manry J., Michailidis E., Hoffmann H.-H., Eto S., Garcia-Prat M., et al. Autoantibodies Neutralizing Type I IFNs Are Present in ~4% of Uninfected Individuals over 70 Years Old and Account for ~20% of COVID-19 Deaths. Sci. Immunol. 2021;6:eabl4340. doi: 10.1126/sciimmunol.abl4340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abl4340</ArticleId><ArticleId IdType="pmc">PMC8521484</ArticleId><ArticleId IdType="pubmed">34413139</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet-Ratnasingham E., Morin S., Randolph H.E., Labrecque M., Bélair J., Lima-Barbosa R., Pagliuzza A., Marchitto L., Hultström M., Niessl J., et al. Sustained IFN Signaling Is Associated with Delayed Development of SARS-CoV-2-Specific Immunity. Nat. Commun. 2024;15:4177. doi: 10.1038/s41467-024-48556-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-48556-y</ArticleId><ArticleId IdType="pubmed">38755196</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A., Iwasaki A. Type I and Type III Interferons—Induction, Signaling, Evasion, and Application to Combat COVID-19. Cell Host Microbe. 2020;27:870–878. doi: 10.1016/j.chom.2020.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7255347</ArticleId><ArticleId IdType="pubmed">32464097</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Shin E.-C. The Type I Interferon Response in COVID-19: Implications for Treatment. Nat. Rev. Immunol. 2020;20:585–586. doi: 10.1038/s41577-020-00429-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00429-3</ArticleId><ArticleId IdType="pmc">PMC8824445</ArticleId><ArticleId IdType="pubmed">32788708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z., Ren L., Zhang L., Zhong J., Xiao Y., Jia Z., Guo L., Yang J., Wang C., Jiang S., et al. Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients. Cell Host Microbe. 2020;27:883–890. doi: 10.1016/j.chom.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.017</ArticleId><ArticleId IdType="pmc">PMC7196896</ArticleId><ArticleId IdType="pubmed">32407669</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.S., Park S., Jeong H.W., Ahn J.Y., Choi S.J., Lee H., Choi B., Nam S.K., Sa M., Kwon J.-S., et al. Immunophenotyping of COVID-19 and Influenza Highlights the Role of Type I Interferons in Development of Severe COVID-19. Sci. Immunol. 2020;5:eabd1554. doi: 10.1126/sciimmunol.abd1554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd1554</ArticleId><ArticleId IdType="pmc">PMC7402635</ArticleId><ArticleId IdType="pubmed">32651212</ArticleId></ArticleIdList></Reference><Reference><Citation>Galani I.-E., Rovina N., Lampropoulou V., Triantafyllia V., Manioudaki M., Pavlos E., Koukaki E., Fragkou P.C., Panou V., Rapti V., et al. Untuned Antiviral Immunity in COVID-19 Revealed by Temporal Type I/III Interferon Patterns and Flu Comparison. Nat. Immunol. 2021;22:32–40. doi: 10.1038/s41590-020-00840-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00840-x</ArticleId><ArticleId IdType="pubmed">33277638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhuti D., Rawat A., Guo C.M., Wilson L.A., Mills E.J., Forrest J.I. Interferon Treatments for SARS-CoV-2: Challenges and Opportunities. Infect. Dis. Ther. 2022;11:953–972. doi: 10.1007/s40121-022-00633-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40121-022-00633-9</ArticleId><ArticleId IdType="pmc">PMC9022612</ArticleId><ArticleId IdType="pubmed">35445964</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological Dysfunction Persists for 8 Months Following Initial Mild-to-Moderate SARS-CoV-2 Infection. Nat. Immunol. 2022;23:210–216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnett K.C., Xie Y., Asakura T., Song D., Liang K., Taft-Benz S.A., Guo H., Yang S., Okuda K., Gilmore R.C., et al. An Epithelial-Immune Circuit Amplifies Inflammasome and IL-6 Responses to SARS-CoV-2. Cell Host Microbe. 2023;31:243–259. doi: 10.1016/j.chom.2022.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.12.005</ArticleId><ArticleId IdType="pmc">PMC9731922</ArticleId><ArticleId IdType="pubmed">36563691</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon J., Michelson D.A., Olejnik J., Chowdhary K., Oh H.S., Hume A.J., Galván-Peña S., Zhu Y., Chen F., Vijaykumar B., et al. A Virus-Specific Monocyte Inflammatory Phenotype Is Induced by SARS-CoV-2 at the Immune-Epithelial Interface. Proc. Natl. Acad. Sci. USA. 2022;119:e2116853118. doi: 10.1073/pnas.2116853118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2116853118</ArticleId><ArticleId IdType="pmc">PMC8740714</ArticleId><ArticleId IdType="pubmed">34969849</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipolla B.G., Mandron E., Lefort J.M., Coadou Y., Della Negra E., Corbel L., Le Scodan R., Azzouzi A.R., Mottet N. Effect of Sulforaphane in Men with Biochemical Recurrence after Radical Prostatectomy. Cancer Prev. Res. 2015;8:712–719. doi: 10.1158/1940-6207.CAPR-14-0459.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1940-6207.CAPR-14-0459</ArticleId><ArticleId IdType="pubmed">25968598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R., Hebbar V., Kim B.-R., Chen C., Winnik B., Buckley B., Soteropoulos P., Tolias P., Hart R.P., Kong A.-N.T. In Vivo Pharmacokinetics and Regulation of Gene Expression Profiles by Isothiocyanate Sulforaphane in the Rat. J. Pharmacol. Exp. Ther. 2004;310:263–271. doi: 10.1124/jpet.103.064261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.064261</ArticleId><ArticleId IdType="pubmed">14988420</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagishita Y., Fahey J.W., Dinkova-Kostova A.T., Kensler T.W. Broccoli or Sulforaphane: Is It the Source or Dose That Matters? Molecules. 2019;24:3593. doi: 10.3390/molecules24193593.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24193593</ArticleId><ArticleId IdType="pmc">PMC6804255</ArticleId><ArticleId IdType="pubmed">31590459</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H. Minimap2: Pairwise Alignment for Nucleotide Sequences. Bioinformatics. 2018;34:3094–3100. doi: 10.1093/bioinformatics/bty191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty191</ArticleId><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R., Duggal G., Love M.I., Irizarry R.A., Kingsford C. Salmon Provides Fast and Bias-Aware Quantification of Transcript Expression. Nat. Methods. 2017;14:417–419. doi: 10.1038/nmeth.4197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4197</ArticleId><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>